CONDITION

Pancreatitis in Cats

An inflammatory condition of the pancreas in cats that often presents subtly and may occur alongside other organ conditions.

Why this matters now

Pancreatitis in cats can occur at any age but is most commonly recognised in middle-aged to older cats. Unlike canine pancreatitis, which often has identifiable dietary triggers, feline pancreatitis frequently develops without a clearly identifiable precipitating cause, making it a particularly insidious condition. No breed predisposition has been conclusively established, though some studies suggest Siamese cats may be slightly overrepresented. The condition has historically been underdiagnosed in cats due to its often subtle and non-specific clinical presentation, which can differ substantially from the more dramatic signs typically seen in dogs. Advances in diagnostic capabilities, particularly the development of feline-specific pancreatic lipase immunoreactivity (fPLI) testing, have improved recognition of this condition and revealed it to be considerably more common than previously appreciated.

Feline pancreatitis can present across a spectrum from mild, self-limiting episodes to severe, life-threatening acute disease, with many cats experiencing a chronic or recurrent pattern. Acute pancreatitis may develop rapidly and can produce significant systemic effects, though even acute episodes in cats tend to present with less dramatic signs than in dogs. Chronic pancreatitis, characterised by persistent low-grade inflammation and progressive fibrosis of the pancreatic tissue, is particularly common in cats and may smoulder for extended periods with subtle, intermittent signs that are easily overlooked. A significant proportion of cats with pancreatitis have concurrent inflammatory conditions affecting the liver (cholangitis) and intestines (inflammatory bowel disease), a constellation sometimes referred to as 'triaditis,' which reflects the anatomical proximity and shared inflammatory pathways among these organs in the feline abdomen. Over time, chronic pancreatitis may eventually compromise the endocrine function of the pancreas sufficiently to contribute to the development of diabetes mellitus.

Signals & patterns

Early signals

Decreased appetite or food refusal

A reduction in appetite — ranging from eating less than usual to complete food refusal — is one of the most commonly observed signs of pancreatitis in cats. The change may be subtle, with the cat eating more slowly, leaving food, or showing increased selectivity. In a species where reduced appetite can have serious metabolic consequences (particularly hepatic lipidosis), even mild inappetence warrants attention, especially when it persists beyond a day or two.

Lethargy and withdrawal

Cats with pancreatitis often become quieter, less interactive, and more inclined to seek out secluded resting spots. They may show reduced interest in their surroundings, decreased play behaviour, and less responsiveness to social contact. Because cats naturally spend significant time resting, distinguishing pathological lethargy from normal behaviour can be challenging, but a noticeable change from the individual cat's baseline is significant.

Subtle changes in posture or movement

Abdominal discomfort may manifest as a hunched posture, reluctance to be handled around the abdomen, or slight changes in movement quality. Unlike dogs, cats with pancreatitis rarely show the dramatic abdominal pain behaviours (prayer posture, vocalisation) that can make the condition more immediately recognisable. Some cats may show a preference for positions that avoid pressure on the abdomen, such as sitting in a sphinx-like posture rather than lying on their side.

Mild vomiting or nausea

While vomiting is a prominent feature of canine pancreatitis, it occurs less consistently in cats, and when present may be infrequent or mild. Signs of nausea without overt vomiting — such as lip licking, drooling, turning away from food, or brief episodes of retching — may be the primary gastrointestinal signs observed. These subtle indicators of nausea can be easily overlooked in a species that may naturally be less demonstrative when unwell.

Mild dehydration

Reduced food and water intake combined with the inflammatory process can lead to mild dehydration, which may be detectable through slightly tacky gums, reduced skin turgor, or a subtle increase in the time it takes for the skin to return to normal position when gently tented. In mild cases, the dehydration may not be obvious but can contribute to the cat's general sense of unwellness.

Later signals

Persistent inappetence and weight loss

Sustained food refusal over several days or longer represents a significant concern in cats, particularly obese cats, due to the risk of hepatic lipidosis developing secondary to prolonged fasting. Progressive weight loss may occur in cats with chronic or recurrent pancreatitis as cumulative periods of reduced intake and impaired nutrient absorption take their toll. The weight loss may be gradual and not immediately apparent, particularly in cats with a generous initial body condition.

Jaundice (icterus)

A yellowish discolouration of the skin, gums, and the whites of the eyes may develop if pancreatitic inflammation extends to or compresses the common bile duct, impeding the flow of bile from the liver. Jaundice may also indicate concurrent cholangitis or hepatic involvement. This sign is relatively specific and, when observed, typically prompts urgent investigation to determine the underlying cause.

Hypothermia

Unlike many inflammatory conditions that produce fever, cats with moderate to severe pancreatitis may develop low body temperature (hypothermia), which carries prognostic significance. Hypothermia in this context reflects the severity of the systemic illness and the body's diminishing ability to maintain normal homeostatic functions. A cold cat that is also lethargic and inappetent may be demonstrating signs of significant systemic compromise.

Signs of concurrent triaditis

When pancreatitis occurs alongside cholangitis and inflammatory bowel disease, the clinical picture may include a combination of gastrointestinal signs (diarrhoea, vomiting), hepatic signs (jaundice, abnormal liver enzymes), and the general signs of pancreatitis. The overlapping symptomatology of these three conditions can create a complex clinical picture that reflects the multi-organ nature of the inflammatory process. Identifying the full extent of organ involvement is important for comprehensive management.

Click to read about the biological mechanisms

How this is usually investigated

Investigating suspected pancreatitis in cats can be challenging due to the often non-specific nature of the clinical signs and the limitations of individual diagnostic tests. A combination of clinical findings, laboratory assessments, and imaging is typically used to build a composite picture, as no single test provides a definitive diagnosis in all cases. The investigation also aims to identify concurrent conditions, particularly hepatobiliary disease and inflammatory bowel disease, which frequently accompany feline pancreatitis.

Feline pancreatic lipase immunoreactivity (fPLI/Spec fPL)

Purpose: This blood test measures a lipase isoenzyme that is specific to the pancreas, providing a more sensitive and specific indicator of pancreatic inflammation than general lipase or amylase measurements. Elevated fPLI levels support a diagnosis of pancreatitis, though the degree of elevation does not always correlate with the severity of the disease. This test has substantially improved the ability to diagnose feline pancreatitis, which was historically very difficult to confirm without biopsy.
Considerations: While fPLI is the most useful non-invasive marker currently available for feline pancreatitis, it is not perfect — false negatives can occur, particularly in chronic low-grade disease, and mildly elevated results require clinical correlation. The test measures the presence of pancreatic-origin lipase in the bloodstream but does not distinguish between acute and chronic disease. Serial measurements over time may provide more information than a single result.

Abdominal ultrasonography

Purpose: Ultrasound examination of the pancreas and surrounding structures can reveal changes consistent with pancreatitis, including pancreatic enlargement, altered echogenicity (changes in the brightness of the tissue on ultrasound), peripancreatic fluid or fat inflammation, and dilation of the pancreatic or bile ducts. Ultrasound also allows assessment of the liver and intestines for concurrent disease, which is particularly relevant given the frequency of triaditis in cats.
Considerations: The feline pancreas can be technically challenging to visualise on ultrasound, and normal-appearing pancreatic ultrasound does not exclude pancreatitis, particularly mild or chronic forms. The sensitivity of ultrasound for detecting feline pancreatitis is lower than for canine pancreatitis. The quality of the examination depends substantially on operator experience and equipment, and gas within the gastrointestinal tract can obscure the pancreatic region.

Blood biochemistry and haematology

Purpose: Comprehensive blood work helps assess the systemic impact of pancreatitis, identify concurrent organ involvement, and screen for complications. Elevated liver enzymes may indicate concurrent hepatic involvement or biliary obstruction, whilst glucose and fructosamine levels can reveal diabetogenic effects of pancreatic damage. Electrolyte imbalances, changes in white blood cell counts, and alterations in coagulation parameters all contribute to understanding the severity and scope of the disease.
Considerations: Many of the blood work changes associated with feline pancreatitis are non-specific and can occur with numerous other conditions. Normal blood work does not exclude pancreatitis. The combination of abnormalities, rather than any single parameter, is most informative when interpreted alongside clinical signs and imaging findings.

Cobalamin and folate levels

Purpose: Measuring serum cobalamin (vitamin B12) and folate levels can provide information about intestinal absorptive function, which is particularly relevant when concurrent inflammatory bowel disease is suspected as part of a triaditis complex. Low cobalamin levels are common in cats with chronic gastrointestinal and pancreatic disease and can impair recovery if not addressed through supplementation.
Considerations: Cobalamin deficiency can both result from and contribute to gastrointestinal dysfunction, creating a cycle that benefits from interruption through supplementation. Cobalamin levels should be assessed before supplementation is initiated, as prior supplementation can mask underlying deficiency. The relationship between cobalamin status and clinical outcomes in cats with pancreatitis is an area of ongoing research.

Pancreatic biopsy (surgical or laparoscopic)

Purpose: Histological examination of pancreatic tissue provides the most definitive information about the type and severity of pancreatic disease, allowing distinction between acute necrotising pancreatitis, chronic pancreatitis with fibrosis, and other pancreatic pathologies. Biopsy also allows sampling of the liver and intestines during the same procedure when triaditis is suspected. This provides the most comprehensive assessment of the multi-organ inflammatory process.
Considerations: Pancreatic biopsy is invasive and requires general anaesthesia, which carries additional risk in cats that may already be systemically unwell. The procedure is not routinely performed in all cases and is typically reserved for situations where the diagnosis remains uncertain, the disease is not responding to empirical management, or concurrent conditions need histological characterisation. Sampling error can occur if the biopsy is taken from a region of the pancreas that does not adequately represent the overall disease process.

Options & trade-offs

Management of pancreatitis in cats focuses on supportive care, pain management, nutritional support, and addressing concurrent conditions. Unlike in dogs, dietary fat restriction has not been shown to play as significant a role in feline pancreatitis management, and the approach to nutrition in affected cats differs in important ways. The management strategy is typically tailored to the severity and chronicity of the disease, with acute episodes often requiring more intensive support.

Fluid therapy and electrolyte correction

Intravenous or subcutaneous fluid therapy addresses dehydration, supports renal perfusion, and helps correct electrolyte imbalances that may develop through reduced intake and vomiting. In acute or severe cases, intravenous fluid therapy is typically administered in a hospital setting with careful monitoring. For cats with milder presentations or chronic disease, subcutaneous fluid supplementation may be provided as part of outpatient management.

Trade-offs: Intravenous fluid therapy requires hospitalisation and venous catheter placement, which can be stressful for cats. Careful monitoring is needed to avoid fluid overload, particularly in cats with concurrent cardiac disease. The duration and intensity of fluid therapy depend on the severity of dehydration and the cat's ongoing losses and intake.

Pain management

Recognising and treating pain is a critical component of feline pancreatitis management, even though cats may not display obvious pain behaviours. Analgesic options may include opioids (such as buprenorphine, which can be administered transmucosally in cats), non-steroidal anti-inflammatory drugs (with caution given the potential for concurrent renal or gastrointestinal effects), or gabapentin for neuropathic pain components. Effective pain management can improve appetite, reduce stress, and support recovery.

Trade-offs: Assessing pain in cats is inherently challenging, and the absence of obvious pain behaviours does not indicate the absence of pain. Some analgesic agents may cause sedation, which can be difficult to distinguish from disease-related lethargy. The choice of analgesic must consider the individual cat's overall health status, particularly renal function and hydration status.

Nutritional support and early feeding

Current understanding favours early nutritional support in cats with pancreatitis, in contrast to the traditional approach of withholding food. Maintaining nutritional intake helps prevent hepatic lipidosis, supports intestinal barrier function, and provides the nutrients needed for tissue healing. If the cat will not eat voluntarily, appetite stimulants (such as mirtazapine), assisted feeding (syringe feeding of palatable, easily digestible food), or feeding tube placement may be considered. The diet does not need to be specifically low-fat, as dietary fat restriction has not been shown to be as important in feline pancreatitis as it may be in dogs.

Trade-offs: Syringe feeding can be stressful for cats and may create food aversions if not handled carefully. Feeding tube placement (oesophagostomy or nasooesophageal) requires sedation or anaesthesia but can provide a reliable route for nutrition, medication, and hydration. The decision to place a feeding tube involves balancing the benefits of reliable nutritional support against the procedural requirements and the individual cat's tolerance.

Anti-nausea medication

Anti-emetic and anti-nausea medications such as maropitant (Cerenia) and ondansetron can help control vomiting and reduce the nausea that contributes to inappetence. Addressing nausea is often an important step in restoring voluntary food intake. These medications may be administered by injection during initial treatment and transitioned to oral forms as the cat improves.

Trade-offs: Anti-nausea medications address the symptom rather than the underlying cause of the nausea. Some cats may require multiple agents to achieve adequate nausea control. Long-term use may be needed in cats with chronic or recurrent pancreatitis, and the cost and practicality of ongoing medication administration are practical considerations.

Management of concurrent conditions

When pancreatitis occurs as part of a triaditis complex, management of the concurrent cholangitis and inflammatory bowel disease is essential for overall improvement. This may include antibiotics for suspected bacterial cholangitis, immunomodulatory medications such as prednisolone for the inflammatory bowel component, ursodiol (ursodeoxycholic acid) to support bile flow, and cobalamin supplementation. Addressing diabetes mellitus, if it has developed secondary to pancreatic damage, adds an additional layer to the management plan.

Trade-offs: Managing multiple concurrent conditions increases the complexity of the treatment plan, the number of medications, and the monitoring requirements. Some treatments for one component (such as corticosteroids for IBD) may potentially influence another component (such as glucose regulation in a cat with developing diabetes). Balancing the needs of multiple organ systems requires careful coordination and regular reassessment.

Common misconceptions

Misconception:

"If a cat is not vomiting dramatically, it cannot have pancreatitis"

Reality:

Feline pancreatitis often presents with far more subtle signs than its canine counterpart, and many cats with confirmed pancreatitis do not vomit at all. The most common signs in cats are non-specific — reduced appetite, lethargy, and withdrawal — which can be easily attributed to other causes or overlooked entirely. The absence of dramatic gastrointestinal signs does not exclude pancreatitis, and the subtlety of feline clinical presentations is a major reason the condition has been historically underdiagnosed.

Misconception:

"Pancreatitis in cats is always caused by a high-fat diet"

Reality:

Unlike in dogs, where dietary indiscretion and high-fat meals are recognised triggers, the cause of pancreatitis in cats is frequently idiopathic — meaning no specific trigger can be identified. Whilst various factors including infections, trauma, certain medications, and other inflammatory conditions have been associated with feline pancreatitis, in many cases the initiating cause remains unknown. Dietary fat restriction has not been demonstrated to be as important in preventing or managing feline pancreatitis as it may be in canine cases.

Misconception:

"Pancreatitis is always an acute, one-time event"

Reality:

In cats, chronic pancreatitis — characterised by persistent, low-grade inflammation and progressive fibrosis — may be more common than acute pancreatitis. The chronic form can persist for months or years with subtle, waxing and waning signs that may go unrecognised. Additionally, cats may experience recurrent acute episodes, and the distinction between acute and chronic forms is not always clear-cut on clinical presentation alone. The chronic nature of feline pancreatitis means that ongoing awareness and monitoring, rather than single-episode management, is often appropriate.

Understanding feline pancreatitis as a condition that can present subtly and often coexists with other inflammatory conditions can help frame the importance of attentive observation of changes in a cat's eating behaviour, energy levels, and general demeanour. Cats with a history of pancreatitis may be at risk of recurrent episodes, and awareness of the signs — however subtle — can support earlier recognition. The relationship between pancreatic health, liver function, and intestinal integrity in cats is an area of active veterinary research, and understanding of the interconnected inflammatory processes continues to develop. Many cats with pancreatitis, including those with chronic forms, can maintain good quality of life with appropriate management and monitoring.

Last reviewed: 24 April 2026 · Dr Alastair Greenway MRCVS